Mark L Helman

Title: Mark L Helman: Innovator in Obesity and Diabetes Treatment

Introduction

Mark L Helman is a notable inventor based in New Orleans, LA (US). He has made significant contributions to the field of medical treatments, particularly in addressing obesity and diabetes. His innovative approaches have the potential to impact many lives.

Latest Patents

Mark L Helman holds a patent for "Compositions and methods for treating obesity and diabetes." This patent discloses methods of modulating the expression of genes linked to various metabolic processes. These include adipocytokine signaling, carbohydrate metabolism, and insulin signaling. The patent also outlines methods for treating conditions such as hyperlipidemia, obesity, cardiovascular disease, and diabetes. The composition involves administering at least one isolated glyceollin to animals in need of treatment.

Career Highlights

Throughout his career, Mark has worked with reputable organizations, including the Administrators of the Tulane Educational Fund and the United States Department of Agriculture. His work in these institutions has allowed him to further his research and develop innovative solutions for health-related issues.

Collaborations

Mark has collaborated with notable individuals in his field, including Matthew E Burow and Stephen M Boue. These partnerships have contributed to the advancement of his research and the development of effective treatments.

Conclusion

Mark L Helman is a distinguished inventor whose work in treating obesity and diabetes showcases his commitment to improving health outcomes. His innovative methods and collaborations highlight the importance of research in addressing critical health challenges.